1. Home
  2. PBYI vs PAMT Comparison

PBYI vs PAMT Comparison

Compare PBYI & PAMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • PAMT
  • Stock Information
  • Founded
  • PBYI 2010
  • PAMT 1980
  • Country
  • PBYI United States
  • PAMT United States
  • Employees
  • PBYI N/A
  • PAMT N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • PAMT Trucking Freight/Courier Services
  • Sector
  • PBYI Health Care
  • PAMT Industrials
  • Exchange
  • PBYI Nasdaq
  • PAMT Nasdaq
  • Market Cap
  • PBYI 263.4M
  • PAMT 223.5M
  • IPO Year
  • PBYI N/A
  • PAMT 1985
  • Fundamental
  • Price
  • PBYI $4.91
  • PAMT $10.08
  • Analyst Decision
  • PBYI Strong Buy
  • PAMT Hold
  • Analyst Count
  • PBYI 1
  • PAMT 1
  • Target Price
  • PBYI $7.00
  • PAMT $13.00
  • AVG Volume (30 Days)
  • PBYI 635.5K
  • PAMT 7.8K
  • Earning Date
  • PBYI 11-06-2025
  • PAMT 10-28-2025
  • Dividend Yield
  • PBYI N/A
  • PAMT N/A
  • EPS Growth
  • PBYI 59.87
  • PAMT N/A
  • EPS
  • PBYI 0.74
  • PAMT N/A
  • Revenue
  • PBYI $211,995,000.00
  • PAMT $623,270,000.00
  • Revenue This Year
  • PBYI N/A
  • PAMT N/A
  • Revenue Next Year
  • PBYI N/A
  • PAMT $12.19
  • P/E Ratio
  • PBYI $6.61
  • PAMT N/A
  • Revenue Growth
  • PBYI N/A
  • PAMT N/A
  • 52 Week Low
  • PBYI $2.32
  • PAMT $9.68
  • 52 Week High
  • PBYI $6.12
  • PAMT $21.01
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 46.97
  • PAMT 46.78
  • Support Level
  • PBYI $4.58
  • PAMT $9.68
  • Resistance Level
  • PBYI $6.12
  • PAMT $11.29
  • Average True Range (ATR)
  • PBYI 0.40
  • PAMT 0.44
  • MACD
  • PBYI -0.05
  • PAMT 0.04
  • Stochastic Oscillator
  • PBYI 20.06
  • PAMT 54.34

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About PAMT PAMT CORP Common Stock

PAMT Corp is a holding company that is engaged in providing truckload dry van carriers transporting general commodities throughout the continental United States, as well as the Canadian provinces of Ontario and Quebec. It has one reportable segment being motor carrier.

Share on Social Networks: